NDC 50090-4622-01 - Oxybutynin Chloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-4622
- Requested NDC
- 50090-4622-01
- Package NDCs from labels
- 50090-4622-0, 50090-4622-1, 50090-4622-3, 50090-4622-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2024-06-03
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Oxybutynin Chloride - A-S Medication Solutions | A-S Medication Solutions | 2024-06-03 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 50090-4622-0 | 2023-02-06 | OXYBUTYNIN CHLORIDE TABLETS, USP Rx only |
| 50090-4622-1 | 2023-02-06 | OXYBUTYNIN CHLORIDE TABLETS, USP Rx only |
| 50090-4622-3 | 2023-02-06 | OXYBUTYNIN CHLORIDE TABLETS, USP Rx only |
| 50090-4622-0 | 2023-01-30 | OXYBUTYNIN CHLORIDE TABLETS, USP Rx only |
| 50090-4622-1 | 2023-01-30 | OXYBUTYNIN CHLORIDE TABLETS, USP Rx only |
| 50090-4622-3 | 2023-01-30 | OXYBUTYNIN CHLORIDE TABLETS, USP Rx only |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-4622-0 | Oxybutynin Chloride | 30 in 1 BOTTLE | TABLET | 30 | 11 | |
| 50090-4622-1 | Oxybutynin Chloride | 100 in 1 BOTTLE | TABLET | 100 | 11 | |
| 50090-4622-3 | Oxybutynin Chloride | 90 in 1 BOTTLE | TABLET | 90 | 11 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-4622 | OXYBUTYNIN CHLORIDE TABLET [A-S MEDICATION SOLUTIONS] | 11 | Current NDC, Legacy NDC, 3 package rows | 20240604_39a2d144-0c10-4aec-9fa4-0adc24b332eb.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-4622-0 | EA - Each | 50090-4622 | 341581ec-a389-4c39-8913-c2b1c57eb2e7 | 1 | 2022-12-07 |
| 50090-4622-1 | EA - Each | 50090-4622 | 79095bee-3fb1-4c38-be46-3f6c2720332e | 1 | 2022-12-07 |
| 50090-4622-3 | EA - Each | 50090-4622 | f9e87985-b8f4-4b6d-9ca1-73269e326b73 | 1 | 2022-12-07 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Proficient Rx LP | e3f0c249-8085-4979-823a-820e233a284f | 2022-06-01 | Warnings, Adverse reactions | 863664 L9F3D9RENQ |
| oxybutynin chloride | OXYBUTYNIN CHLORIDE | Proficient Rx LP | 88f08450-559e-4038-aad1-051e4ab283cf | 2022-06-01 | Warnings, Adverse reactions | L9F3D9RENQ |
| OXYBUTYNIN CHLORIDE | OXYBUTYNIN CHLORIDE | Leading Pharma, LLC | b73b8338-8045-448f-87a6-3d289227d00e | 2022-02-14 | Warnings, Adverse reactions | 863664 L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Lannett Company, Inc. | 615f3d95-197c-4fec-b81f-c26449c93c3b | 2020-02-21 | Warnings, Adverse reactions | L9F3D9RENQ |
| Oxybutynin Chloride Extended Release | OXYBUTYNIN CHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | e985e201-2fb3-4781-9790-a1a3db1ae2a1 | 2017-10-20 | Warnings, Adverse reactions | L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 58136f28-70c1-4cf2-bcd7-858c5609431a | 2016-06-15 | Warnings, Adverse reactions | 863664 L9F3D9RENQ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.